Stimulant medication and the hyperactive adolescent: myths and facts.
There is a widespread myth that when hyperactive or attentionally disabled youth reach puberty, stimulant medication ceases to be an effective and appropriate means of treatment. Since there is no scientific data to support this myth, its origin and maintenance are attributed to nonrational beliefs about stimulant medication, hyperactivity, and adolescence, as well as to methodological factors which have hampered accurate data-gathering by professionals.
D000293:Adolescent; D001288:Attention / Q000187:drug effects; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000523:psychology; D003913:Dextroamphetamine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*; D012306:Risk; D019966:Substance-Related Disorders / Q000523:psychology
D008774:Methylphenidate; D003913:Dextroamphetamine